Lower riskMedical device recall · FDA · Published July 14, 2023
Waldemar Link MobileLink Acetabular Cup System: Incorrect Offset Labeling
Waldemar Link recalls MobileLink Acetabular Cup System with incorrect offset labeling. This may affect surgical implants for hip replacements. Affected units have specific UDI-DI and lot numbers.
“Waldemar Link MobileLink Acetabular Cup System: Incorrect Offset Labeling.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/57647-waldemar-link-mobilelink-acetabular-cup-system-incorrect-offset-labeling. Based on FDA recall #Z-2641-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2641-2023%22&limit=1).
The FDA announced on July 14, 2023, that Waldemar Link GmbH & Co. KG is recalling MobileLink Acetabular Cup System components due to incorrect labeling of the offset. The agency issued recall number Z-2641-2023 for the voluntary Class II action.
How to tell if you have it
Brand: Waldemar Link
Product: MobileLink Acetabular Cup System, Shell/Insert Adapter for Shell 74-80mm, Insert Size F, +12mm Offset 20 degrees
The product is labeled with an incorrect offset. The FDA classifies this as a Class II recall.
Context
GovInfoNow's records show Waldemar Link GmbH & Co. KG has 21 other recalls on record since December 4, 2018. Other recent recalls of similar products include Encore Medical EMPOWR Acetabular System Recall (January 5, 2026) and U2 Total Knee System: Incorrect Implant Orientation Risk (March 19, 2026).
How to tell if you have this one
Check for the UDI-DI number 04026575182329 and lot numbers 210526/0771 through 210526/0784 on the product packaging or label.
Brand
Waldemar Link
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the UDI-DI number 04026575182329 and lot numbers 210526/0771 through 210526/0784 on the product packaging or label.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “Domestic distribution to AL, NJ, NV.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Nevada, New Jersey.
Recall timeline
FDA published this recall 3 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2641-2023 (July 14, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2641-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.